<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD06160000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q8TDS4</UniProt_ID>
  <Seq_Length>363</Seq_Length>
  <Molecule_Weight>41850</Molecule_Weight>
  <KEGG_ID>hsa:338442</KEGG_ID>
  <Orthology_ID>K08402</Orthology_ID>
  <Function_Summary>Acts as a high affinity receptor for both nicotinic acid (also known as niacin) and (D)-beta-hydroxybutyrate and mediates increased adiponectin secretion and decreased lipolysis through G(i)-protein-mediated inhibition of adenylyl cyclase. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet. Mediates nicotinic acid-induced apoptosis in mature neutrophils. Receptor activation by nicotinic acid results in reduced cAMP levels which may affect activity of cAMP-dependent protein kinase A and phosphorylation of target proteins, leading to neutrophil apoptosis. The rank order of potency for the displacement of nicotinic acid binding is 5-methyl pyrazole-3-carboxylic acid = pyridine-3-acetic acid </Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>3</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>G-protein coupled receptor 109A</Alias>
      <Alias>Niacin receptor 1</Alias>
      <Alias>Nicotinic acid receptor</Alias>
      <Alias>G-protein coupled receptor HM74A</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with nicotinic acid to initiate a change in cell activity.</Detail>
      <Keyword>Nicotinic acid receptor activity</Keyword>
      <Ontology_ID>GO:0070553</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with a purine nucleotide and transmitting the signal to a heterotrimeric G-protein complex to initiate a change in cell activity.</Detail>
      <Keyword>Purinergic nucleotide receptor activity, G-protein coupled</Keyword>
      <Ontology_ID>GO:0045028</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>187</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>198</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>311</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>317</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids.</Detail>
      <Keyword>Negative regulation of lipid catabolic process</Keyword>
      <Ontology_ID>GO:0050995</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the regulated release of adiponectin from a cell or group of cells.</Detail>
      <Keyword>Positive regulation of adiponectin secretion</Keyword>
      <Ontology_ID>GO:0070165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of neutrophil apoptosis.</Detail>
      <Keyword>Positive regulation of neutrophil apoptosis</Keyword>
      <Ontology_ID>GO:0033031</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of apoptosis in neutrophils.</Detail>
      <Keyword>Neutrophil apoptosis</Keyword>
      <Ontology_ID>GO:0001781</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <molStructure/>
  <Molecule_Seq>
    <Protein_Seq>MNRHHLQDHFLEIDKKNCCVFRDDFIVKVLPPVLGLEFIFGLLGNGLALWIFCFHLKSWKSSRIFLFNLAVADFLLIICLPFLMDNYVRRWDWKFGDIPCRLMLFMLAMNRQGSIIFLTVVAVDRYFRVVHPHHALNKISNRTAAIISCLLWGITIGLTVHLLKKKMPIQNGGANLCSSFSICHTFQWHEAMFLLEFFLPLGIILFCSARIIWSLRQRQMDRHAKIKRAITFIMVVAIVFVICFLPSVVVRIRIFWLLHTSGTQNCEVYRSVDLAFFITLSFTYMNSMLDPVVYYFSSPSFPNFFSTLINRCLQRKMTGEPDNNRSTSVELTGDPNKTRGAPEALMANSGEPWSPSYLGPTSP</Protein_Seq>
    <DNA_Seq>ACCACACAGACACACACCTCCTTGCTGGAGCATTCACTAGGCGAGGCGCTCCATCGGACTCACTAGCCGCACTCATGAATCGGCACCATCTGCAGGATCACTTTCTGGAAATAGACAAGAAGAACTGCTGTGTGTTCCGAGATGACTTCATTGTCAAGGTGTTGCCGCCGGTGTTGGGGCTGGAGTTTATCTTCGGGCTTCTGGGCAATGGCCTTGCCCTGTGGATTTTCTGTTTCCACCTCAAGTCCTGGAAATCCAGCCGGATTTTCCTGTTCAACCTGGCAGTGGCTGACTTTCTACTGATCATCTGCCTGCCCTTCCTGATGGACAACTATGTGAGGCGTTGGGACTGGAAGTTTGGGGACATCCCTTGCCGGCTGATGCTCTTCATGTTGGCTATGAACCGCCAGGGCAGCATCATCTTCCTCACGGTGGTGGCGGTAGACAGGTATTTCCGGGTGGTCCATCCCCACCACGCCCTGAACAAGATCTCCAATCGGACAGCAGCCATCATCTCTTGCCTTCTGTGGGGCATCACTATTGGCCTGACAGTCCACCTCCTGAAGAAGAAGATGCCGATCCAGAATGGCGGTGCAAATTTGTGCAGCAGCTTCAGCATCTGCCATACCTTCCAGTGGCACGAAGCCATGTTCCTCCTGGAGTTCTTCCTGCCCCTGGGCATCATCCTGTTCTGCTCAGCCAGAATTATCTGGAGCCTGCGGCAGAGACAAATGGACCGGCATGCCAAGATCAAGAGAGCCATCACCTTCATCATGGTGGTGGCCATCGTCTTTGTCATCTGCTTCCTTCCCAGCGTGGTTGTGCGGATCCGCATCTTCTGGCTCCTGCACACTTCGGGCACGCAGAATTGTGAAGTGTACCGCTCGGTGGACCTGGCGTTCTTTATCACTCTCAGCTTCACCTACATGAACAGCATGCTGGACCCCGTGGTGTACTACTTCTCCAGCCCATCCTTTCCCAACTTCTTCTCCACTTTGATCAACCGCTGCCTCCAGAGGAAGATGACAGGTGAGCCAGATAATAACCGCAGCACGAGCGTCGAGCTCACAGGGGACCCCAACAAAACCAGAGGCGCTCCAGAGGCGTTAATGGCCAACTCCGGTGAGCCATGGAGCCCCTCTTATCTGGGCCCAACCTCTCCTTAAATAACCATGCCAAGAAGGGACATTGTCACCAAGAACCAGGATCTCTGGAGAAACAGTTGGGCTGTTGCATCGAGTAATGTCACTGGACTCGGCCTAAGGTTTCCTGGAACTTCCAGATTCAGAGAATGCGATTTAGGGAAACGGTGGCAGATGAGTGGGAGACTGGTTGCAAGGTGTGACCGCAGGAATCCTGGAGGAATAGAGAGTAAAGCTTCTAGGCATCTGAAACTTTTGCTTCATCTCTGACGCTCGCAGGACTGAAGATGGGCAAATTGTAGGCATTTCTGCTGAGCAGAGTTGGAGCCAGAGATCTACTTGTGACTTGTTGGCCTTCTTCCCACATCTGCCTCAGACTGGAGGGGGCTCAGCTCCTGGGGTGATATCTAGCCTGCTTGTGAGCTCTAGCAGGGATAAGGAGAGCTGAGATTGGAGGGAATTGTGTTGCTCCTGGAGGGAGCCCAGGCATCATTAAACAAGCCAGTAGGTCACCTGGCTTCCGTGGACCAATTCATCTTTCAGACAAGCTTTAGCAGAAATGGACTCAGGGAAGAGACTCACACGCTTTGGTTAATATCTGTGTTTCCGGTGGGTGTAATAGGGGATTAGCCCCAGAAGGGACTGAGCTAAACAGTGTTATTATGGGAAAGGAAATGGCATTGCTGCTTTCAACCAGCGACTAATGCAATCCATTCCTCTCTTGTTTATAGTAATCTAAGGGTTGGGCAGTTAAAACGGCTTCAGGATAGAAAGCTGTTTCCCACCTCTGTTTGCTTTTAACATTAAAAGGGAAATGTGCCTCTGCCCCACAGTTAGAGGGGTGCACGTTCCTCCTGGTTCCTTCGCTTGTGTTTCTGTACTTACCAAAAATCTACCATTTCAATAAATTTTGATAGGAGACAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Spleen</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Adipose tissue</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Mature neutrophils</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>HCAR2</Gene_Name>
    <Gene_Alias>GPR109A; HCA2; HM74A; NIACR1</Gene_Alias>
    <Gene_ID>338442</Gene_ID>
    <Genbank_ACCN>NM_177551</Genbank_ACCN>
    <Protein_ACCN>NP_808219</Protein_ACCN>
    <HGNC_ID>24827</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/338442</Gene_URL>
    <UCSC_ID>uc001ucx.1</UCSC_ID>
    <EMBL_ID>ENSG00000182782</EMBL_ID>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>Model of Hydroxycarboxylic acid receptor 2</PDB_Title>
      <PDB_ID>ASD06160000_1</PDB_ID>
      <Resolution>-1.0</Resolution>
      <Has_Ligand>No</Has_Ligand>
    </PDB>
  </PDB_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD06162001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06162002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06162003</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>